Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Hamish Baillie | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-executive Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| The Biotech Growth Trust PLC | ||||
b)
| LEI
| 549300Z41EP32MI2DN29
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary 25p shares
GB0000385517
| ||||
b)
| Nature of the transaction
| Acquisition of Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
3,000 ordinary 25p shares
930.55 pence per share
| ||||
e)
| Date of the transaction
| 27 November 2024 | ||||
f)
| Place of the transaction
| London Stock Exchange (XLON) |
Name of authorised official of issuer responsible for making notification:
Katherine Manson, for and on behalf of Frostrow Capital LLP
Company Secretary to THE BIOTECH GROWTH TRUST PLC